Relitively new member but have not seen any comment on this report on h/c. perhaps someone could express their view of it.I viewed it on 050722(1)pdf
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling